Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
disabled diaphragm; I suffered severe pain at left ear, neck, shoulder, scalp; I suffered severe pain at left ear; severe pain at upper torso; I suffered severe pain at neck; severe pain at scalp; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of diaphragmatic disorder in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced diaphragmatic disorder (Verbatim: disabled diaphragm), shoulder pain (Verbatim: I suffered severe pain at left ear, neck, shoulder, scalp), ear pain (Verbatim: I suffered severe pain at left ear), pain (Verbatim: severe pain at upper torso), neck pain (Verbatim: I suffered severe pain at neck) and scalp pain (Verbatim: severe pain at scalp). The outcome of the diaphragmatic disorder, shoulder pain, ear pain, pain, neck pain and scalp pain were not reported. It was unknown if the reporter considered the diaphragmatic disorder, shoulder pain, ear pain, pain, neck pain and scalp pain to be related to Shingrix. It was unknown if the company considered the diaphragmatic disorder, shoulder pain, ear pain, pain, neck pain and scalp pain to be related to Shingrix. Additional Information: GSK Receipt Date: 10-APR-2025 This case was reported by a patient via interactive digital media. The reporter suffered severe pain at left ear, neck, shoulder, scalp, upper torso, disabled diaphragm.